ACD22-VCMMAE, DCDT2980S, FCU2803, RG-7593, RO5541072-000
CD22, SIGLEC2, BL-CAM, SIGLEC-2, Siglec2, SIGLEC2FLJ22814
Lyophilized from sterile PBS, pH 7.4. Normally 5 % – 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
|Formulation & Reconstitution||
|Storage & Shipping||
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized proteins are shipped at ambient temperature.
12 months from date of dispatch
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
Anti-CD22 (pinatuzumab biosimilar) mAb
Price: 50μg $80.00 ; 100 μg $160.00
SKU: BME100029 Category: Biosimilar reference antibodies
Figure 1. ELISA plate pre-coated by 2 μg/ml (100 μl/well) Human CD22, hFc-His tagged protein (PME100005) can bind Anti-CD22 Neutralizing antibody in a linear range of 3.2-400 ng/ml.
Figure 2. HEK293 cell line transfected with irrelevant protein (B) and human CD22 (A) were surface stained with Anti-CD22 mAb 1 μg/ml (pinatuzumab) followed by Alexa 488-conjugated anti-human IgG secondary antibody.